InterStudy Publications, a division of Decision Resources, announces the release of its Competitive Edge Regional Market Analysis Spring 2004, which finds that, despite a continuing trend of HMO total enrollment loss at a national level, more than 25% of metropolitan statistical areas (MSAs) experienced a net gain in HMO enrollment between July 1, 2001 and July 1, 2003.

"During this time frame, 41.3% of small MSAs (defined as having a population of fewer than 250,000) experienced growth in HMO enrollment," said Rebecca Waller, project manager for InterStudy Publications. "In contrast, only 22% of large markets experienced a gain in HMO enrollment."

About Competitive Edge

InterStudy publishes the InterStudy Competitive Edge series semi-annually. The Regional Market Analysis is the third in a three-part series on HMOs, and examines market structure and dynamics of metropolitan markets served by HMOs. The HMO Directory is the first report in the series, and Part II, The HMO Industry Report, analyzes plan growth and characteristics associated with growth in HMOs.

About InterStudy Publications

InterStudy Publications, a division of Decision Resources, offers data, directories, and analyses of the ever-evolving managed care industry. InterStudy tracks changes and trends in HMO and PPO services, enrollment, and profitability. Visit InterStudy Publications at http://www.interstudypublications.com/.

About Decision Resources

Decision Resources, Inc., (http://www.decisionresources.com/) is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Frank Sama    InterStudy Publications    781-296-2553    fsama@dresources.com 

SOURCE: InterStudy Publications

CONTACT: Frank Sama of InterStudy Publications, +1-781-296-2553,
fsama@dresources.com

Multiple Barriers to Uptake Associated With Promising Radioimmunotherapies For Non-Hodgkin's Lymphoma May Hinder Market

View Now